278 related articles for article (PubMed ID: 28243990)
21. Carrier rate of APC I1307K is not increased in inflammatory bowel disease patients of Ashkenazi Jewish origin.
Silverberg MS; Clelland C; Murphy JE; Steinhart AH; McLeod RS; Greenberg GR; Cohen Z; Siminovitch KA
Hum Genet; 2001 Mar; 108(3):205-10. PubMed ID: 11354631
[TBL] [Abstract][Full Text] [Related]
22. A meta-analysis of the clinicopathological characteristics and survival outcomes of inflammatory bowel disease associated colorectal cancer.
Reynolds IS; O'Toole A; Deasy J; McNamara DA; Burke JP
Int J Colorectal Dis; 2017 Apr; 32(4):443-451. PubMed ID: 28078433
[TBL] [Abstract][Full Text] [Related]
23. Association of the macrophage migration inhibitory factor gene--173G/C polymorphism with inflammatory bowel disease: a meta-analysis of 4296 subjects.
Zhang H; Ma L; Dong LQ; Shu C; Xu JL
Gene; 2013 Sep; 526(2):228-31. PubMed ID: 23707797
[TBL] [Abstract][Full Text] [Related]
24. Dysplasia and colorectal cancer in inflammatory bowel disease: a result of inflammation or an intrinsic risk?
Breynaert C; Vermeire S; Rutgeerts P; Van Assche G
Acta Gastroenterol Belg; 2008; 71(4):367-72. PubMed ID: 19317276
[TBL] [Abstract][Full Text] [Related]
25. Temporal trend in inpatient mortality in inflammatory bowel disease-associated colorectal cancer vs non-inflammatory colorectal cancer: a nationwide retrospective study.
Flores E; Mbachi C; Achebe I; Asotibe J; Palomera-Tejeda E; Vohra I; Udechukwu V; Kotwal V
Int J Colorectal Dis; 2021 Apr; 36(4):701-708. PubMed ID: 33063223
[TBL] [Abstract][Full Text] [Related]
26. Associations between Gene Polymorphisms in Pro-inflammatory Cytokines and the Risk of Inflammatory Bowel Disease: A Meta-analysis.
Liu W; Wang C; Tang L; Yang H
Immunol Invest; 2021 Nov; 50(8):869-883. PubMed ID: 32847380
[TBL] [Abstract][Full Text] [Related]
27. Colorectal Cancer Risk in Patients With Lynch Syndrome and Inflammatory Bowel Disease.
Derikx LA; Smits LJ; van Vliet S; Dekker E; Aalfs CM; van Kouwen MC; Nagengast FM; Nagtegaal ID; Hoogerbrugge N; Hoentjen F
Clin Gastroenterol Hepatol; 2017 Mar; 15(3):454-458.e1. PubMed ID: 27521512
[TBL] [Abstract][Full Text] [Related]
28. Colorectal cancer in patients with inflammatory bowel disease: can we predict risk?
Andersen V; Halfvarson J; Vogel U
World J Gastroenterol; 2012 Aug; 18(31):4091-4. PubMed ID: 22919240
[TBL] [Abstract][Full Text] [Related]
29. The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study.
Baars JE; Looman CW; Steyerberg EW; Beukers R; Tan AC; Weusten BL; Kuipers EJ; van der Woude CJ
Am J Gastroenterol; 2011 Feb; 106(2):319-28. PubMed ID: 21045815
[TBL] [Abstract][Full Text] [Related]
30. 5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease.
Terdiman JP; Steinbuch M; Blumentals WA; Ullman TA; Rubin DT
Inflamm Bowel Dis; 2007 Apr; 13(4):367-71. PubMed ID: 17206695
[TBL] [Abstract][Full Text] [Related]
31. Bactericidal/permeability increasing protein gene polymorphism and inflammatory bowel diseases: meta-analysis of five case-control studies.
Fan L; Fu G; Ding Y; Lv P; Li H
Int J Colorectal Dis; 2017 Mar; 32(3):433-435. PubMed ID: 28035462
[TBL] [Abstract][Full Text] [Related]
32. Association between IL-10 rs3024505 and susceptibility to inflammatory bowel disease: A systematic review and meta-analysis.
Liu M; Yuan W; Park S
Cytokine; 2022 Jan; 149():155721. PubMed ID: 34628128
[TBL] [Abstract][Full Text] [Related]
33. The
Li J; Zhu Y; Zhou Y; Jiang H; Chen Z; Lu B; Shen X
Genet Test Mol Biomarkers; 2020 Dec; 24(12):835-844. PubMed ID: 33290140
[No Abstract] [Full Text] [Related]
34. Patients' knowledge and fear of colorectal cancer risk in inflammatory bowel disease.
Lopez A; Collet-Fenetrier B; Belle A; Peyrin-Biroulet L
J Dig Dis; 2016 Jun; 17(6):383-91. PubMed ID: 27129893
[TBL] [Abstract][Full Text] [Related]
35. Age-Related Survival Differences in Patients With Inflammatory Bowel Disease-Associated Colorectal Cancer: A Population-Based Cohort Study.
Bogach J; Pond G; Eskicioglu C; Seow H
Inflamm Bowel Dis; 2019 Nov; 25(12):1957-1965. PubMed ID: 31066449
[TBL] [Abstract][Full Text] [Related]
36. Associations of Polymorphisms in mir-196a2, mir-146a and mir-149 with Colorectal Cancer Risk: A Meta-Analysis.
Xu L; Tang W
Pathol Oncol Res; 2016 Apr; 22(2):261-7. PubMed ID: 26208586
[TBL] [Abstract][Full Text] [Related]
37. Association of T Helper 1 Cytokine Gene Single Nucleotide Polymorphisms with Ulcerative Colitis and Crohn's Disease.
Ebrahimi Daryani N; Sadr M; Soltani S; Saghazadeh A; Moossavi S; Shahkarami S; Farhadi E; Rezaei N
Dig Dis; 2019; 37(1):21-32. PubMed ID: 30134230
[TBL] [Abstract][Full Text] [Related]
38. Colorectal Cancer in Inflammatory Bowel Diseases: A Population-Based Study in Utah.
Jewel Samadder N; Valentine JF; Guthery S; Singh H; Bernstein CN; Wan Y; Wong J; Boucher K; Pappas L; Rowe K; Bronner M; Ulrich CM; Burt RW; Curtin K; Smith KR
Dig Dis Sci; 2017 Aug; 62(8):2126-2132. PubMed ID: 28050782
[TBL] [Abstract][Full Text] [Related]
39. Multi-target stool DNA test in the surveillance of inflammatory bowel disease: a cross-sectional cohort study.
Klepp P; Kisiel JB; Småstuen MC; Røseth A; Andersen SN; Vatn MH; Ahlquist DA; Moum BA; Brackmann S
Scand J Gastroenterol; 2018 Mar; 53(3):273-278. PubMed ID: 29313389
[TBL] [Abstract][Full Text] [Related]
40. Rate of early/missed colorectal cancers after colonoscopy in older patients with or without inflammatory bowel disease in the United States.
Wang YR; Cangemi JR; Loftus EV; Picco MF
Am J Gastroenterol; 2013 Mar; 108(3):444-9. PubMed ID: 23295277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
